Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.
about
Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairmentRemifentanil for analgesia-based sedation in the intensive care unitAccidental subcutaneous remifentanil infusion as a cause of delayed awakening after craniotomyEffect of remifentanil on mitochondrial oxygen consumption of cultured human hepatocytes.Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesityPharmacological studies of methoxycarbonyl etomidate's carboxylic acid metaboliteDistinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the MetaboliteEffects of the opioid remifentanil on the arrhythmogenicity of epinephrine in halothane-anesthetized dogs.Comparison of the effects of remifentanil andalfentanil on cardiovascular response to nasotracheal intubation: A prospective, randomized, double-blind study.Partial intravenous anesthesia in cats and dogs.The comparison of preemptive effects of propofol, remifentanil and ketamine on post-operative pain scores and analgesic requirements in elective lower abdominal surgery under general anesthesia: A randomized, double-blinded studyPopulation pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.
P2860
Q24806101-1E6212EC-27BD-40E6-99B4-BBB1E775FD66Q24806245-DB70153F-1DB6-4124-914C-3E4A9BA9DC4FQ30467484-765303F2-696E-4498-91CA-F75E9899872AQ34428320-6DEE17F7-F52C-4A42-922B-82680FB9230AQ34798389-7DE27DDC-3D29-4085-A73A-F4D00489F5C5Q35795130-9DF6ECA1-F8C0-4BA6-BAEE-98F02EF6370BQ36709331-C38AF2B0-FB9A-452A-ADAB-E18DC4A58634Q36742391-B597DBAB-E207-464F-ACE5-F67A9CCAE82BQ37661084-2576319B-D52C-4091-ACEC-CED2E63B1F6FQ38133520-22972515-1616-4159-90E8-0D555A20C07DQ41881474-0AC387A2-DD85-44C1-A4CF-A1B9626EB200Q47152342-6178496C-0643-41FE-B506-5F2B58CC67AAQ55022470-94EA4B53-9AEC-4B5B-A831-2423A3CD1E50
P2860
Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@ast
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@en
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@nl
type
label
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@ast
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@en
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@nl
prefLabel
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@ast
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@en
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@nl
P2093
P1476
Comparative pharmacokinetics a ...... 90291) and alfentanil in dogs.
@en
P2093
P304
P407
P577
1997-04-01T00:00:00Z